Q1WB
NVO

Quest 10 Wealth Builders’s Novo Nordisk NVO Stock Holding History

Quest 10 Wealth Builders’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-76
Closed -$2.79K – 805
2026
Q1 		$2.79K Hold
76
– – ﹤0.01% 594
2025
Q4 		$3.87K Sell
76
-24
-24% -$1.23K ﹤0.01% 522
2025
Q3 		$5.55K Hold
100
– – 0.01% 474
2025
Q2 		$6.9K Hold
100
– – 0.01% 450
2025
Q1 		$6.94K Sell
100
-82
-45% -$6.77K 0.01% 427
2024
Q4 		$15.7K Buy
+182
New +$19.7K 0.02% 335

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Quest 10 Wealth Builders's NVO Position: Q2 2026 in Review

Quest 10 Wealth Builders sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 76 shares — an estimated $2.79K sold.

Quest 10 Wealth Builders first reported a position in NVO in Q4 2024 and held it in 6 quarters. The position peaked at $15.7K in Q4 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Quest 10 Wealth Builders reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Quest 10 Wealth Builders sold 76 Novo Nordisk shares in Q2 2026, an estimated $2.79K.
  • Quest 10 Wealth Builders first reported a position in Novo Nordisk in Q4 2024 and held it in 6 quarters.
  • Quest 10 Wealth Builders's Novo Nordisk position peaked at $15.7K in Q4 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Quest 10 Wealth Builders's 13F filing for Q2 2026, filed 24 Jul 2026.